1
|
Joseph D, Lesueur C, Zerizer F, Fenot A, Alvarez JC, Larabi IA. Characterization of Extensive 2-Fluoro deschloroketamine (2F-DCK) Metabolism in Pooled Human Liver Microsomes (pHLM), Urine, and Hair from an Addicted Patient Using High-Resolution Accurate Mass (HRAM) Spectrometry. J Anal Toxicol 2023:7190129. [PMID: 37279563 DOI: 10.1093/jat/bkad030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 03/08/2023] [Accepted: 06/01/2023] [Indexed: 06/08/2023] Open
Abstract
2-Fluoro-deschloroketamine (2F-DCK) is a ketamine derivative involved in acute intoxications and deaths. The aim of this study is to investigate its metabolism using pHLM, and to apply it to authentic samples (urine, hair, seized materials) from a drug user. 2F-DCK (100 µM) incubates with pHLM were analyzed by LC-HRAM (Q-Exactive, Thermo Fisher Scientific®) according to a previously published protocol. Spectra annotation was performed using Compound Discoverer® software and the metabolic scheme was drawn using Chemdraw software. Urine (200 µL) and hair (previously decontaminated using dichloromethane and segmented into 3 segments: A 0-3 cm, B 3-6cm, C 6-9cm) were extracted with a mixture of hexane/ethyl acetate (1:1) and chloroform/isopropanol (4:1). 10 µL of both reconstituted residues were analyzed by LC-HRAM. Hair was also analyzed by LC-MS-MS (TSQ Vantage, Thermo Fisher Scientific®) for 2F-DCK and DCK quantification. The two presumed 2F-DCK crystals consumed by the patient were dissolved in methanol (1 mg/mL) and 10 µL were analyzed by LC-MS-MS (Quantum Access Max, Thermo Fisher Scientific®). Twenty-six putative 2F-DCK metabolites were identified, 15 being reported for the first time. Thirteen metabolites were detected in pHLM, 10 confirmed in both the patient's urine and hair, and all found in at least one of the 2 samples. 23 metabolites were detected in urine, and 20 in hair. Our research confirms the reliability of nor-2F-DCK as a target analyte and suggest OH- dihydro-nor-2F-DCK and dehydro-nor-2F-DCK as new target analytes in urine and hair, respectively. This is the first study to report deschloroketamine as a 2F-DCK metabolite using pHLM and to determine its concentrations in hair (A/B/C, 885/1500/1850 pg/mg) following chronic use. Finally, the two seized crystals contained 2F-DCK at 67% and 96% with traces of deschloroketamine (0.4% and 0.6%) related to cross-contamination by container exchange.
Collapse
Affiliation(s)
- Delphine Joseph
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Camille Lesueur
- Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, 92380 Garches, France; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France
| | - Fanny Zerizer
- Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, 92380 Garches, France; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France
| | - Alexia Fenot
- Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, 92380 Garches, France; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France
| | - Jean Claude Alvarez
- Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, 92380 Garches, France; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France
| | - Islam Amine Larabi
- Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, 92380 Garches, France; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France
| |
Collapse
|
2
|
Štefková-Mazochová K, Danda H, Dehaen W, Jurásek B, Šíchová K, Pinterová-Leca N, Mazoch V, Krausová BH, Kysilov B, Smejkalová T, Vyklický L, Kohout M, Hájková K, Svozil D, Horsley RR, Kuchař M, Páleníček T. Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats. Br J Pharmacol 2021; 179:65-83. [PMID: 34519023 DOI: 10.1111/bph.15680] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Revised: 08/13/2021] [Accepted: 08/16/2021] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND AND PURPOSE Deschloroketamine (DCK), a structural analogue of ketamine, has recently emerged on the illicit drug market as a recreational drug with a modestly long duration of action. Despite it being widely used by recreational users, no systematic research on its effects has been performed to date. EXPERIMENTAL APPROACH Pharmacokinetics, acute effects, and addictive potential in a series of behavioural tests in Wistar rats were performed following subcutaneous (s.c.) administration of DCK (5, 10, and 30 mg·kg-1 ) and its enantiomers S-DCK (10 mg·kg-1 ) and R-DCK (10 mg·kg-1 ). Additionally, activity at human N-methyl-d-aspartate (NMDA) receptors was also evaluated. KEY RESULTS DCK rapidly crossed the blood brain barrier, with maximum brain levels achieved at 30 min and remaining high at 2 h after administration. Its antagonist activity at NMDA receptors is comparable to that of ketamine with S-DCK being more potent. DCK had stimulatory effects on locomotion, induced place preference, and robustly disrupted PPI. Locomotor stimulant effects tended to disappear more quickly than disruptive effects on PPI. S-DCK had more pronounced stimulatory properties than its R-enantiomer. However, the potency in disrupting PPI was comparable in both enantiomers. CONCLUSION AND IMPLICATIONS DCK showed similar behavioural and addictive profiles and pharmacodynamics to ketamine, with S-DCK being in general more active. It has a slightly slower pharmacokinetic profile than ketamine, which is consistent with its reported longer duration of action. These findings have implications and significance for understanding the risks associated with illicit use of DCK.
Collapse
Affiliation(s)
| | - Hynek Danda
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,3rd Faculty of Medicine, Charles University, Prague 10, Czech Republic
| | - Wim Dehaen
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague 6, Czech Republic
| | - Bronislav Jurásek
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 6, Czech Republic
| | - Klára Šíchová
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
| | - Nikola Pinterová-Leca
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,3rd Faculty of Medicine, Charles University, Prague 10, Czech Republic
| | - Vladimír Mazoch
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
| | - Barbora Hrčka Krausová
- Department of Cellular Neurophysiology, Institute of Physiology, CAS, Prague 4, Czech Republic
| | - Bohdan Kysilov
- Department of Cellular Neurophysiology, Institute of Physiology, CAS, Prague 4, Czech Republic
| | - Tereza Smejkalová
- Department of Cellular Neurophysiology, Institute of Physiology, CAS, Prague 4, Czech Republic
| | - Ladislav Vyklický
- Department of Cellular Neurophysiology, Institute of Physiology, CAS, Prague 4, Czech Republic
| | - Michal Kohout
- Department of Organic Chemistry, University of Chemistry and Technology, Prague 6, Czech Republic
| | - Kateřina Hájková
- Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 6, Czech Republic.,Department of Analytical Chemistry, University of Chemistry and Technology, Prague 6, Czech Republic
| | - Daniel Svozil
- CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague 6, Czech Republic.,CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics, CAS, Prague 4, Czech Republic
| | - Rachel R Horsley
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
| | - Martin Kuchař
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 6, Czech Republic
| | - Tomáš Páleníček
- Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.,3rd Faculty of Medicine, Charles University, Prague 10, Czech Republic
| |
Collapse
|
3
|
Hájková K, Jurásek B, Čejka J, Štefková K, Páleníček T, Sýkora D, Kuchař M. Synthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry. Drug Test Anal 2020; 12:343-360. [PMID: 31670910 DOI: 10.1002/dta.2726] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2019] [Revised: 10/23/2019] [Accepted: 10/24/2019] [Indexed: 12/31/2022]
Abstract
Deschloroketamine (2-(methylamino)-2-phenyl-cyclohexanone) is a ketamine analog belonging to a group of dissociative anesthetics, which have been distributed within the illicit market since 2015. However, it was also being sold as 'ketamine' misleading people to believe that they were getting genuine ketamine. Dissociative anesthetics have also come to the attention of the psychiatric field due to their potential properties in the treatment of depression. At present, there is a dearth of information on deschloroketamine related to its metabolism, biodistribution, and its mechanism of action. We have therefore carried out a metabolomics study for deschloroketamine via non-targeted screening of urine samples employing liquid chromatography combined with high-resolution mass spectrometry. We developed and validated a multiple reaction monitoring method using a triple quadrupole instrument to track metabolites of deschloroketamine. Furthermore, significant metabolites of deschloroketamine, (trans-dihydrodeschloroketamine, cis- and trans-dihydronordeschloroketamine, and nordeschloroketamine), were synthesized in-house. The prepared standards were utilized in the developed multiple reaction monitoring method. The quantification method for serum samples provided intra-day accuracy ranging from 86% to 112% with precision of 3% on average. The concentrations of cis/trans-dihydronordeschloroketamines and trans-dihydrodeschloroketamine were lower than 10 ng/mL, nordeschloroketamine and deschloroketamine ranged from 0.5 to 860 ng/mL in real samples. The quantification method for brain tissue provided intra-day accuracy ranging from 80% to 125% with precision of 7% on average. The concentrations of cis/trans-dihydronordeschloroketamines and trans-dihydrodeschloroketamine ranged from 0.5 to 70 ng/g, nordeschloroketamine and deschloroketamine varied from 0.5 to 4700 ng/g in real samples.
Collapse
Affiliation(s)
- Kateřina Hájková
- Forensic Laboratory of Biologically Active Substances, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Analytical Chemistry, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Brain Electrophysiology, National Institute of Mental Health, Topolová, Klecany, Czech Republic
| | - Bronislav Jurásek
- Forensic Laboratory of Biologically Active Substances, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Chemistry of Natural Compounds, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Experimental Neurobiology, National Institute of Mental Health, Topolová, Klecany, Czech Republic
| | - Jan Čejka
- Department of Solid State Chemistry UCT Prague, Technická 5, Prague, Czech Republic
| | - Kristýna Štefková
- Department of Experimental Neurobiology, National Institute of Mental Health, Topolová, Klecany, Czech Republic
| | - Tomáš Páleníček
- Department of Experimental Neurobiology, National Institute of Mental Health, Topolová, Klecany, Czech Republic.,3rd Faculty of Medicine, Charles University in Prague, Ruská, Prague, Czech Republic
| | - David Sýkora
- Department of Analytical Chemistry, UCT Prague, Technická 5, Prague, Czech Republic
| | - Martin Kuchař
- Forensic Laboratory of Biologically Active Substances, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Chemistry of Natural Compounds, UCT Prague, Technická 5, Prague, Czech Republic.,Department of Experimental Neurobiology, National Institute of Mental Health, Topolová, Klecany, Czech Republic
| |
Collapse
|